Q2 2019 Holdings
Filed 2019-08-13 | 21 holdings | $92.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $58.1M | 504,210 | 63.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $23.0M | 892,946 | 24.9% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $10.9M | 2,874,602 | 11.8% |
| Shockwave Medical Inc(SWAVUSD) | COM | 82489T104 | $51.5K | 901,256 | 0.1% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $42.2K | 962,903 | 0.0% |
| Obseva SA | COM | H5861P103 | $25.5K | 2,252,460 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $20.4K | 677,164 | 0.0% |
| Zogenix | COM | 98978L204 | $17.3K | 362,010 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $16.9K | 428,731 | 0.0% |
| Constellation Pharmaceuticals(CNST) | COM | 210373106 | $8.9K | 726,677 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $8.3K | 376,889 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $8.2K | 609,081 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $5.5K | 474,015 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.2K | 426,781 | 0.0% |
| La Jolla Pharmaceuticals(LJPC) | COM | 503459604 | $4.8K | 518,102 | 0.0% |
| Milestone Pharmaceuticals Inc(MIST) | COM | 59935V107 | $4.0K | 148,560 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $3.1K | 743,876 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $2.5K | 4,149,378 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $514 | 249,463 | 0.0% |
| Gemphire Therapeutics | COM | 36870A108 | $382 | 471,524 | 0.0% |
| Proteostasis Therapeutics Inc | COM | 74373B109 | $128 | 130,733 | 0.0% |